180 related articles for article (PubMed ID: 21993183)
1. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.
Mahmoud F; Tampi RR
Am J Geriatr Pharmacother; 2011 Dec; 9(6):405-12. PubMed ID: 21993183
[TBL] [Abstract][Full Text] [Related]
2. Reversible Valproic Acid-Induced Parkinsonism and Cognitive Impairment in an Elderly Patient With Bipolar Disorder I.
Hassamal S; Waller S; Reese K; Testa C
Turk Psikiyatri Derg; 2016; 27(3):213-217. PubMed ID: 27711942
[TBL] [Abstract][Full Text] [Related]
3. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
Haymond J; Ensom MH
Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
[TBL] [Abstract][Full Text] [Related]
4. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
Masmoudi K; Gras-Champel V; Masson H; Andréjak M
Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
[TBL] [Abstract][Full Text] [Related]
5. [Valproate induced parkinsonism].
Park-Matsumoto YC; Tazawa T
No To Shinkei; 1998 Jan; 50(1):81-4. PubMed ID: 9493204
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
Nasrallah HA; Ketter TA; Kalali AH
J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
[TBL] [Abstract][Full Text] [Related]
7. Valproate reversibly reduces neurite outgrowth by human SY5Y neuroblastoma cells.
Qian Y; Zheng Y; Tiffany-Castiglioni E
Brain Res; 2009 Dec; 1302():21-33. PubMed ID: 19766605
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Parkinsonism in older patients receiving sodium valproate.
Macphee GJ; Stewart DA
Mov Disord; 2007 Jun; 22(8):1211. PubMed ID: 17443705
[No Abstract] [Full Text] [Related]
9. Valproic acid overdose: a case report and review of therapy.
Houghton BL; Bowers JB
MedGenMed; 2003 Jan; 5(1):5. PubMed ID: 12827066
[TBL] [Abstract][Full Text] [Related]
10. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
11. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
[TBL] [Abstract][Full Text] [Related]
12. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
Munhoz RP; Werneck LC; Teive HA
Clin Neurol Neurosurg; 2010 Jun; 112(5):431-5. PubMed ID: 20347518
[TBL] [Abstract][Full Text] [Related]
13. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
14. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
15. The use of valproate in an elderly population with affective symptoms.
Kando JC; Tohen M; Castillo J; Zarate CA
J Clin Psychiatry; 1996 Jun; 57(6):238-40. PubMed ID: 8666559
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.
Suzuki T; Uchida H; Takeuchi H; Nakajima S; Nomura K; Tanabe A; Yagi G; Watanabe K; Kashima H
Hum Psychopharmacol; 2009 Dec; 24(8):628-38. PubMed ID: 19946935
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
[TBL] [Abstract][Full Text] [Related]
18. [Parkinsonism induced by sodium valproate].
del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
[TBL] [Abstract][Full Text] [Related]
19. [Valproic acid relieved marked rigidity in three patients with end-stage parkinsonism].
Sayama S; Fujimoto K; Nakano I
Rinsho Shinkeigaku; 1998 Jun; 38(6):495-8. PubMed ID: 9847665
[TBL] [Abstract][Full Text] [Related]
20. The use of divalproex in the treatment of addictive disorders.
Myrick H; Brady KT
Psychopharmacol Bull; 2003; 37 Suppl 2():89-97. PubMed ID: 15021864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
